These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30106425)

  • 1. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example.
    Altraif I
    Saudi Med J; 2018 Aug; 39(8):842-845. PubMed ID: 30106425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Guide to the Economics of Hepatitis C Virus Cure in 2017.
    Linas BP; Nolen S
    Infect Dis Clin North Am; 2018 Jun; 32(2):447-459. PubMed ID: 29778265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized US Efforts to Eliminate Hepatitis C.
    Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a hepatitis C virus treatment strategy to achieve the 2030 vision for Saudi Arabia.
    Al-Judaibi B
    Saudi J Gastroenterol; 2017; 23(1):71. PubMed ID: 28139504
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
    Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thanetkongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Sochoo S; Pongsuwan N; Poovorawan K; Tangkijvanich P; Poovorawan Y
    PLoS One; 2018; 13(4):e0196301. PubMed ID: 29689073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis c eradication: It's now or never…let's get to work.
    Abdo AA
    Saudi J Gastroenterol; 2016; 22(4):249-50. PubMed ID: 27488318
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C could be virtually eliminated by 2030, experts believe.
    Watts G
    BMJ; 2014 Apr; 348():g2700. PubMed ID: 24721972
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEDICINE. Global control of hepatitis C virus.
    Cox AL
    Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus genotypes in Saudi Arabia.
    Osoba AO
    Saudi Med J; 2002 Jan; 23(1):7-12. PubMed ID: 11938356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.
    Fleurence RL; Collins FS
    JAMA; 2023 Apr; 329(15):1251-1252. PubMed ID: 36892976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatitis C: cost of eradication ].
    Nau JY
    Rev Med Suisse; 2014 Jan; 10(415):306-7. PubMed ID: 24624702
    [No Abstract]   [Full Text] [Related]  

  • 15. The Second Biggest Infectious Disease Killer in the U.S.: Hepatitis C Virus Infection and Steps Towards its Elimination in Rhode Island and Beyond.
    Taylor LE
    R I Med J (2013); 2020 Jun; 103(5):19-21. PubMed ID: 32481774
    [No Abstract]   [Full Text] [Related]  

  • 16. Tracing the epidemic history of hepatitis C virus genotypes in Saudi Arabia.
    Khan A; Al Balwi M; AlAyyar L; AlAbdulkareem I; Albekairy A; Aljumah A
    Infect Genet Evol; 2017 Aug; 52():82-88. PubMed ID: 28458032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.
    Memish ZA; Knawy BA; El-Saed A
    Int J Infect Dis; 2010 Feb; 14(2):e115-20. PubMed ID: 19540786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatitis C virus core antigenemia in Saudi drug users.
    Alzahrani AJ
    Saudi Med J; 2005 Oct; 26(10):1645-6. PubMed ID: 16228075
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C: What lies ahead and can we afford it?
    Howie H; Hutchinson SJ
    J Viral Hepat; 2004 Sep; 11 Suppl 1():28-33. PubMed ID: 15357861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute hepatitis C in HIV coinfection: Is this a chance for achieving microelimination?
    Rockstroh J; Boesecke C
    United European Gastroenterol J; 2019 May; 7(4):465-466. PubMed ID: 31065363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.